이노스펙(IOSP) 2026년 3분기 실적 발표회: 매출 성장 및 마진 개선

이노스펙(Innospec Inc., NASDAQ: IOSP)은 2026년 3분기 실적 발표에서 3개 사업 부문 모두 매출과 영업이익이 증가하며 전반적인 성장세를 기록했다고 밝혔다. 퍼포먼스 케미컬 부문이 수익성 개선을 견인한 가운데, 경영진은 노스캐롤라이나 공장 증설·개선 작업과 유전 서비스 부문의 활동 회복이 향후 추가 성장을 뒷받침할 것으로 전망했다.

핵심 요약

• 3분기 매출은 전년 동기 대비 7% 증가한 4억 7,360만 달러를 기록했으며, 총이익률은 0.9%포인트 상승한 27.3%를 나타냈다.
• 조정 EBITDA는 4,420만 달러에서 5,140만 달러로 증가했다. 조정 주당순이익(EPS)은 1.12달러에서 1.29달러로 늘어났다.
• 퍼포먼스 케미컬 부문의 영업이익은 판매량이 5% 감소했음에도 불구하고 총이익률이 18.8%로 개선되면서 84% 급증한 1,690만 달러를 기록했다.
• 유전 서비스 부문은 중동 지역의 사업 활동 지연과 원자재 비용 상승으로 분기 실적이 일부 제한되었으나, 매출은 13% 증가하고 영업이익은 40% 늘어났다.
• 이노스펙의 9월 말 기준 현금 및 현금성 자산은 2억 5,190만 달러이며 차입금은 없다. 경영진은 4분기에 4,000만 달러에서 5,000만 달러 규모의 잉여현금흐름(FCF)을 창출할 것으로 예상한다.
• 이사회는 반기 배당금을 주당 0.94달러로 인상했으며, 이는 연간 배당금 기준 9% 증가한 수준이다.

주요 재무 실적

사업 및 영업 실적

퍼포먼스 케미컬

매출은 6% 증가한 1억 8,050만 달러를 기록했다. 원자재 가격 상승에 따른 가격 및 제품 믹스 효과(+12%)가 판매량 감소(-5%)와 환율 부정적 영향(-1%)을 상쇄했다.

총이익률은 15.1%에서 18.8%로 확대되었으며, 영업이익은 84% 증가한 1,690만 달러를 기록했다. 경영진은 노스캐롤라이나 공장의 효율성 개선 작업이 연말까지 완료될 것으로 예상하고 있다. 이번 작업은 퍼스널 케어 및 기타 기존 제품 전반의 생산 능력, 생산성 및 수율을 개선하기 위한 것이다.

제품에 대해 고객사 재인증을 받을 필요는 없으나, 경영진은 손실된 매출을 회복하는 데 시간이 걸릴 것이라고 언급했다. 성장세는 급격한 반등보다는 점진적인 우상향 곡선을 그릴 것으로 전망된다. 또한 이노스펙은 설비 개선 이후 신규 기술과 고마진 제품 생산에 우선순위를 둘 계획이며, 범용 제품으로 공장 가동률을 채우지는 않을 방침이다.

퓨얼 스페셜티

매출은 3%의 판매량 증가와 2%의 가격 및 믹스 개선에 힘입어 5% 증가한 1억 8,070만 달러를 기록했다. 총이익률은 31.5%를 나타냈으며, 영업이익은 1% 증가한 3,560만 달러를 기록했다.

경영진은 가격 전가 메커니즘에 시차가 존재함에도 불구하고 계약상 가격 결정 메커니즘을 통해 변동성이 큰 원자재 및 운임 비용을 계속 관리해 왔다고 설명했다. 회사는 퓨얼 스페셜티 부문을 안정적인 마진을 유지하는 사업으로 평가하며, 지속적인 견조한 실적과 계절적 수요가 이어질 것으로 기대하고 있다.

유전 서비스

매출은 13% 증가한 1억 1,240만 달러를 기록했다. 제품 믹스 악화로 인해 총이익률은 1.8%포인트 하락한 28.2%를 기록했으나, 영업이익은 40% 증가한 670만 달러를 기록했다.

마찰저감제 공장 증설에 따른 판매량 증가가 성장을 이끌었다. 다만, 중동의 기존 생산 및 유전 자극 사업 지연과 높은 원자재 비용으로 인해 실적은 경영진의 기대치에 미치지 못했다.

경영진은 마찰저감제 수요가 계속 견조할 것으로 보았다. 멕시코 시장은 장기적으로 잠재적 기회가 될 수 있으나 실적 발표 시점 기준으로 이노스펙의 멕시코 매출 발생 건은 없다.

경영진 가이던스

• 퍼포먼스 케미컬의 4분기 실적은 3분기와 유사할 것으로 예상된다. 경영진은 노스캐롤라이나 공장 개선 작업이 2027년 성장을 견인할 핵심 요소라고 평가하고 있다.
• 유전 서비스 부문은 중동 지역 고객사의 활동이 재개됨에 따라 4분기에 전분기 대비 실적이 개선될 것으로 예상된다.
• 퓨얼 스페셜티 부문의 4분기 마진 수준은 3분기와 대체로 유사하게 유지될 것으로 전망된다.
• 경영진은 연초 이후 투입된 운전자본 투자액 일부가 회수됨에 따라 4분기 잉여현금흐름이 약 4,000만 달러에서 5,000만 달러에 달할 것으로 예상한다.
• 원자재 환경이 비교적 안정적으로 유지된다면, 운전자본 투자 수요가 줄어들면서 2027년 잉여현금흐름은 5,500만 달러에서 6,000만 달러 수준에 다가설 것으로 회사는 전망하고 있다.
• 2026년 자본적 지출(CAPEX)은 약 6,000만 달러가 될 것으로 예상된다.

리스크 및 관전 포인트

중동 지역의 안보 상황으로 인해 이노스펙의 기존 유전 서비스 현장 활동이 지연되었다. 회복 속도는 시추선의 작업 복귀 여부와 회사의 고객 서비스 재개 능력에 달려 있다.

사업 성장, 원자재 및 운임 인플레이션, 재고 증가로 인해 운전자본이 연초 대비 약 8,000만 달러 확대되었다. 경영진은 재고가 적정 수준을 상회할 수 있으며 매출채권에 대한 보다 철저한 관리가 필요함을 인정했다.

퍼포먼스 케미컬의 판매량은 전년 동기 대비 감소세를 이어갔다. 노스캐롤라이나 공장 개선 작업은 예정대로 진행 중이지만, 경영진은 고객사 및 매출 회복이 점진적으로 이루어질 것으로 예상하고 있다.

원자재 및 운임 비용의 변동성은 퓨얼 스페셜티 부문에 여전히 유효한 변수다. 계약상의 가격 전가 메커니즘이 이러한 비용 관리에 도움이 되지만, 일정 부분 시차가 수반된다.

애널리스트 Q&A 주요 내용

애널리스트들은 중동 지역 사업 차질, 노스캐롤라이나 공장 증설·개선, 가격 전가 메커니즘, 현금 창출력에 주목했다.

경영진은 중동 지역의 사업 차질이 마찰저감제 사업보다는 주로 생산 및 유전 자극 작업에 영향을 미쳤다고 밝혔다. 재무적 영향이 사업 부문 전체 실적에서 차지하는 비중이 매우 크지는 않지만, 유전 서비스 부문 실적에 영향을 미칠 만큼은 되었다고 설명했다.

퍼포먼스 케미컬과 관련해 경영진은 공장 개선 일정이 실질적으로 변경되지 않았음을 확인했다. 최우선 과제는 제품 공급의 복구였으며, 이어 효율성, 수율, 생산 능력 및 방한 시설 개선이 뒤따랐다. 고객사의 별도 재인증 절차는 필요하지 않다.

현금흐름과 관련해 경영진은 운전자본이 정상화됨에 따라 4분기에 의미 있는 개선이 이루어질 것으로 예상하고 있다. 이노스펙의 무부채 재무상태표는 자체 성장 투자, 인수합병(M&A), 배당 확대, 자사주 매입 등을 추진할 수 있는 유연성을 제공한다.

실적 발표 전문(Transcript)

전체 실적 발표 컨퍼런스 콜 녹취록

경영진 발표

Operator

Good day, and thank you for standing by. Welcome to the Innospec's Third Quarter 2026 Earnings Release and Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead.

David Jones

Thank you. Welcome to Innospec's quarterly earnings call. This is David Jones, and I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website.

During this call, we will make forward-looking statements, which are predictions and projections about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from the anticipated results implied by such forward-looking statements. The risks and uncertainties are detailed in Innospec's filings with the SEC. Please see the SEC site and Innospec's site for these and related documents.

In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release. The non-GAAP financial measures should not be considered as a substitute for those prepared in accordance with GAAP. They are included as additional items to aid investor understanding of the company's performance and anticipated impact that these items and events had on financial results.

With me today from Innospec are Patrick Williams, President and Chief Executive Officer; and Ian Cleminson, Executive Vice President and Chief Financial Officer. And with that, I'll turn it over to you, Patrick.

Patrick Williams

Thank you, David, and welcome, everyone, to Innospec's Third Quarter 2026 Conference Call. This was a strong quarter for Innospec with all businesses delivering sales growth and operating income improvement. Performance Chemicals sales growth and gross margin improvement drove an 84% operating income increase over last year. The North Carolina plant efficiency upgrades discussed last quarter are scheduled to be completed by year-end. These upgrades will increase capacity, productivity and yields on a wide range of existing personal care and other products.

In parallel, we will continue to focus on commercializing new products to drive further margin and operating income improvement in the coming quarters.

Fuel Specialties had another strong quarter, delivering revenue and operating income growth with margins in our target range. Both volume and price/mix improved as the business has continued to manage well against raw material volatility. We expect continued strong performance and seasonal demand in the coming quarters.

Oilfield Services operating income grew 40% and operating margins expanded driven by improved volumes from our recent DRA plant expansion. Third quarter results were lower than expected on activity delays in our Middle East legacy business, along with elevated raw material costs. We expect sequential improvement in the fourth quarter.

Now I will turn the call over to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian and I will take your questions. Ian?

Ian Cleminson

Thanks, Patrick. Turning to Slide 7 in the presentation. The company's total revenues for the third quarter were $473.6 million, a 7% increase from $441.9 million a year ago. Overall gross margin increased by 0.9 percentage points from last year to 27.3%.

Adjusted EBITDA for the quarter was $51.4 million compared to $44.2 million last year, and net income attributable to Innospec for the quarter was $31.8 million compared to $12.9 million a year ago.

Our GAAP earnings per share were $1.29, and there was no net impact of special items in the quarter.

Last year, we reported GAAP earnings per share of $0.52, which included a negative impact from special items of $0.60 per share. Excluding special items in both years, our adjusted EPS for the quarter was $1.29 compared to $1.12 a year ago.

Turning to Slide 8. Revenues in Performance Chemicals for the third quarter were $180.5 million, up 6% from last year's $170.8 million. Volume reductions of 5% and a negative currency impact of 1% were offset by a positive price/mix of 12%, driven by higher raw material pricing.

Gross margins of 18.8% increased 3.7 percentage points compared to 15.1% in the same quarter in 2025.

Operating income of $16.9 million increased 84% from $9.2 million last year. We expect the fourth quarter results to be similar to this quarter with the plant upgrades in North Carolina the key to unlocking growth in 2027.

Moving on to Slide 9. Revenues in Fuel Specialties for the third quarter were $180.7 million, up 5% from $172 million reported a year ago. Volumes were up 3% with price/mix up 2%.

Fuel Specialties gross margins of 31.5% decreased 0.5 percentage points compared to 35.6% in the same quarter last year.

Operating income of $35.6 million was up 1% from $35.3 million a year ago.

Moving on to Slide 10. Revenues in Oilfield Services for the quarter were $112.4 million, up 13% from the $99.1 million reported a year ago.

Gross margins of 28.2% decreased 1.8 percentage points from last year's 30% on a weaker sales mix.

Operating income of $6.7 million increased 40% from $4.8 million 1 year ago.

Turning to Slide 11. Corporate costs for the quarter were $18.6 million compared with $18.2 million a year ago. The adjusted effective tax rate for the quarter was 24.7% compared to 22.7% last year.

Moving on to Slide 12. Cash from operating activities was $17.4 million before capital expenditures of $15.6 million. As of September 30, Innospec had $251.9 million in cash and cash equivalents and no debt.

And now I'll turn it back over to Patrick for some final comments. Patrick?

Patrick Williams

Thanks, Ian. Again, this quarter, Innospec delivered strong sales and operating income growth with higher margins. Performance Chemicals and Oilfield Services remain our key focus. We expect continued steady and strong results in Fuel Specialties. Operating cash generation was positive in the quarter, and our net cash position remained at over $250 million. We continue to focus on driving increased operating cash flow in the coming quarters with better working capital efficiency.

We have significant balance sheet flexibility for organic investment, M&A, dividend growth and buybacks. This quarter, our Board approved a further increase in our semiannual dividend to $0.94 per share, resulting in an annual dividend increase of 9%.

Now I will turn the call over to the operator, and Ian and I will take your questions.

Operator

[Operator Instructions] We are now going to take our first question, and this one comes from Jon Tanwanteng from CJS Securities.

질의응답

Jonathan Tanwanteng

I was wondering if you could quantify the impact in the oilfield business from delays in the Mid East. And I'm assuming that, that was pipeline attacks in Saudi, number one, in the quarter? And number two, how you expect that business to trend in Q4, assuming a recovery there and the underlying inflation dynamics?

Patrick Williams

Yes, Jon, it's Patrick. It wasn't necessarily impacting the DRA business. More of the impact was on production and stim, and it's just the fact of getting people out in the fields to work while you're having drones bombing over the top of you has been a very difficult situation for that whole area. And the key for us really is making sure that we're back on these rigs when they go back out and that we're servicing the way they need to be serviced.

The impact is probably -- it was probably not a significant percentage, but big enough to make a difference in oilfield. And the hope is from what we're seeing as long as we service the customers as we expect and we have the technology is that we're starting to see some return in business in the fourth quarter, which should really help us out moving forward.

Jonathan Tanwanteng

Got it. And as you head into '27, could you just update us on the outlook for the segment in the coming year, especially if you have potential customers coming in from Latin America and as the dynamic evolves from pipelines to maybe a reopening of the Strait or some other condition change in the Middle East?

Patrick Williams

Yes. So I'll work backwards. If we just stick with the Middle East for a minute, I think that with everything that's going on in that area and other businesses that we're going after, our DRA should remain strong even if the Strait and we have settlements for the Strait of Hormuz than we move forward.

If you look at the general business, we're still waiting to see things move in Latin America. Specific to Mexico, I think you've seen some announcements by President Shinbaum about opening up and putting more money into petrochemicals and petrochemical facilities. And to do that, they've got to fix their crude issue. We're hoping at some time that, that turns, but we have not had any sales into Mexico to date. So it's -- if we had the crystal ball, if all these things came into place, it would obviously look a lot different than it is today. But we still see significant growth -- sequential growth as well moving forward and not [indiscernible] quarter, but in the quarters moving forward in 2027.

Jonathan Tanwanteng

Okay. Great. Next for me, just could you just update us on your expectations for cash and cash flow? You've come down in your net cash balance over the past year. And recognizing you've returned a lot of cash to shareholders, a great job there. But I was wondering if you had any thoughts on where your net cash balance is going to be over the coming year, and how you expect the spending priorities to change, if at all?

Ian Cleminson

Yes. Let me take that one, Jon, it's Ian. What we've seen so far year-to-date is quite a large investment in our working capital. That's expanded by about $80 million since the start of the year. In the fourth quarter, we expect some of that to reverse. And what's driven that is partly the expansion of the business and partly some of the inflation that we've seen coming through the supply chain in terms of raw materials and freights, and that's worked itself through. But no doubt, we're probably carrying a little bit too much inventory. We can be a little bit tighter on some of those receivables. So we've got some work to do in the fourth quarter.

Our view is that we will be much more cash generative in the fourth quarter to the region of about $40 million to $50 million at the free cash flow level. So that takes care of this year. And as we roll into next year, our expectation is that we won't need -- on a stable background with raw materials, relatively stable, we won't need the same level of working capital investment. So we would imagine that we'll be hitting closer to $55 million to $60 million of free cash flow next year. And that's based on a pretty similar level of capital expenditure, around about $60 million last year, and we expect about $60 million this year as well.

Operator

We are now going to take our next question, and this one is from Mike Harrison from Seaport Research Partners.

Michael Harrison

Apologies if I missed it, but a couple of questions on personal care. It sounds like you're expecting the North Carolina plant upgrades to be complete by year-end. I'm just wondering, has the timing moved later there? And if so, what's causing the delays? And I guess the other piece of that question is, is there a requalification process that you need to go through with your customers? Or should we see sales volumes kind of getting back to normal by Q1?

Patrick Williams

Yes, Mike, it's Patrick. We haven't really -- the timing has been about what we expected. The number one priority was to get the plants up and running so that we could provide products to our customers, and that's what we did. The secondary part of the plan was to make sure that we concluded and finished the efficiencies of the plant to make it better, better yields, providing more volume because you have better yields, et cetera, winterizing it, all the things that we had to do. Our number one priority was to get product to our customers. And so the timing of that is exactly what we thought that we would complete all of this by the fourth quarter, and that should happen.

So in regards to recapturing more products or lost sales, I should say, it's going to take some time. We don't have to requalify, but it is going to take some time to go back and recapture some of that business. And that's why we see this -- we do see sequential growth moving forward, but it's just -- it's not going to be that big spike. It's going to be a nice slow curve upwards. And I think the other thing that we're focusing on, too, is the product mix that we put on that plan. We don't want to just load it up with commodity products. We want new products, new technologies that require or we get higher margins from, and that's really the plan moving forward. So it's a plan we've had in place. We're sticking to it. I think the strategy is working, and it should work moving forward in 2027.

Michael Harrison

All right. Very helpful. And then my other question is on the Fuel Specialties business. You guys have these contractual pricing pass-throughs. It looks like price was only up about 2% year-on-year despite what I assume was pretty meaningful raw material inflation. I was just hoping you could talk a little bit about the timing of that pricing pass-through and how that's impacting the margins, either gross margin or operating margin as you look at Fuel Specialties for Q3 and Q4?

Ian Cleminson

Yes, Mike, I'll take that one. We think the Fuel Specialties team has done a good job actually. They've been battling against some really volatile raw material pricing and freight pricing as well. We have managed the gross margins in that business really well. We are 0.5 percentage point down year-over-year. And as you know, we've got all the mechanisms in place as raw materials come through, and there's a little bit of a lag in there. So the level we're at in the fourth (sic) [ third ] quarter is the level we expect to be at in the fourth quarter. We don't see much change there. We think the business has got a handle on it, and we're in control of all of that. So we don't -- I take your point that the price/mix is not up that much, but it's certainly at the gross margin level and the gross profit dollars and the operating income level and the operating margin levels, we're happy where the business is at.

Patrick Williams

And I think, Mike, just to add a little color to what Ian said. I started out with this business and ran this business for quite some time. And we have seen these markets up and down. We've seen high inflation. We've seen recessions. We've seen mega market movements. And it's never been these big run-ups on margins or big rundown on margins. It's always a very well managed and a lot of it's contracts, but it's a very well-managed margin business. So you're never going to see these big spikes in that business. It's just a very stable business, and we've seen that for as long as we've been ahead.

Operator

There are no further questions for today. I will now hand the call back to Patrick Williams for closing remarks.

Patrick Williams

Thank you all for joining us today, and thanks to all our shareholders, customers and Innospec employees for your interest and support. If you have any further questions about Innospec or matters discussed today, please give us a call. We look forward to meeting up with you again to discuss our fourth quarter 2026 results in February. Have a great day.

Operator

Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.